Fidelity Investments’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9
| Closed | -$114 | – | 5757 |
|
|
2024
Q1 | $114 | Buy |
+9
| New | +$114 | ﹤0.01% | 4960 |
|
|
2023
Q3 | – | Sell |
-1
| Closed | -$13 | – | 5670 |
|
|
2023
Q2 | $13 | Buy |
+1
| New | +$13 | ﹤0.01% | 5250 |
|
|
2020
Q3 | – | Sell |
-5,264
| Closed | -$464K | – | 4102 |
|
|
2020
Q2 | $464K | Sell |
5,264
-37,999
| -88% | -$3.35M | ﹤0.01% | 2519 |
|
|
2020
Q1 | $4.84M | Sell |
43,263
-9,863
| -19% | -$1.1M | ﹤0.01% | 1948 |
|
|
2019
Q4 | $13M | Sell |
53,126
-6,277
| -11% | -$1.54M | ﹤0.01% | 1751 |
|
|
2019
Q3 | $20.5M | Buy |
59,403
+135
| +0.2% | +$46.5K | ﹤0.01% | 1561 |
|
|
2019
Q2 | $54.6M | Buy |
59,268
+583
| +1% | +$537K | 0.01% | 1176 |
|
|
2019
Q1 | $93.6M | Buy |
58,685
+444
| +0.8% | +$708K | 0.01% | 939 |
|
|
2018
Q4 | $109M | Buy |
58,241
+643
| +1% | +$1.2M | 0.01% | 812 |
|
|
2018
Q3 | $136M | Buy |
57,598
+6,035
| +12% | +$14.2M | 0.02% | 814 |
|
|
2018
Q2 | $178M | Buy |
51,563
+141
| +0.3% | +$486K | 0.02% | 713 |
|
|
2018
Q1 | $146M | Buy |
51,422
+2,795
| +6% | +$7.93M | 0.02% | 820 |
|
|
2017
Q4 | $125M | Sell |
48,627
-9,686
| -17% | -$24.9M | 0.01% | 893 |
|
|
2017
Q3 | $165M | Sell |
58,313
-11
| -0% | -$31.2K | 0.02% | 758 |
|
|
2017
Q2 | $138M | Buy |
58,324
+2,907
| +5% | +$6.87M | 0.02% | 825 |
|
|
2017
Q1 | $140M | Sell |
55,417
-2,225
| -4% | -$5.61M | 0.02% | 851 |
|
|
2016
Q4 | $130M | Sell |
57,642
-33
| -0.1% | -$74.4K | 0.02% | 856 |
|
|
2016
Q3 | $145M | Buy |
57,675
+192
| +0.3% | +$481K | 0.02% | 815 |
|
|
2016
Q2 | $176M | Buy |
57,483
+7,215
| +14% | +$22.1M | 0.02% | 720 |
|
|
2016
Q1 | $160M | Sell |
50,268
-3,676
| -7% | -$11.7M | 0.02% | 760 |
|
|
2015
Q4 | $277M | Buy |
53,944
+386
| +0.7% | +$1.98M | 0.04% | 518 |
|
|
2015
Q3 | $170M | Buy |
53,558
+69
| +0.1% | +$220K | 0.02% | 710 |
|
|
2015
Q2 | $214M | Buy |
53,489
+270
| +0.5% | +$1.08M | 0.03% | 662 |
|
|
2015
Q1 | $213M | Buy |
53,219
+1,916
| +4% | +$7.65M | 0.03% | 665 |
|
|
2014
Q4 | $252M | Buy |
51,303
+607
| +1% | +$2.98M | 0.03% | 578 |
|
|
2014
Q3 | $206M | Buy |
50,696
+11,244
| +29% | +$45.7M | 0.03% | 650 |
|
|
2014
Q2 | $160M | Buy |
39,452
+3,766
| +11% | +$15.2M | 0.02% | 765 |
|
|
2014
Q1 | $162M | Buy |
35,686
+5,499
| +18% | +$25M | 0.02% | 735 |
|
|
2013
Q4 | $106M | Sell |
30,187
-16,943
| -36% | -$59.4M | 0.01% | 950 |
|
|
2013
Q3 | $194M | Sell |
47,130
-2,748
| -6% | -$11.3M | 0.03% | 629 |
|
|
2013
Q2 | $197M | Buy |
+49,878
| New | +$197M | 0.03% | 591 |
|